Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Co-Source Biomedical Technology is a high-tech biotechnology company based in Hefei, China, specializing in the field of molecular diagnostics and precision medicine. The company focuses on the development, manufacturing, and commercialization of in vitro diagnostic (IVD) reagents and automated instruments, particularly for oncology and infectious disease testing. Utilizing core technologies such as high-throughput sequencing (NGS), digital PCR, and liquid biopsy, Co-Source provides comprehensive solutions for early cancer screening, companion diagnostics, and personalized treatment monitoring. Their product portfolio includes kits for HPV genotyping, EGFR mutation detection, and various other genetic markers. The company operates a state-of-the-art R&D center and GMP-certified manufacturing facilities to support its growing presence in the Chinese diagnostic market. Co-Source aims to improve patient outcomes by providing accurate and accessible molecular testing tools for clinical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Co-Source Biomedical Technology.